Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00094-9/abstract?utm_campaign=update-lanonc&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanonc&_hsenc=p2ANqtz-9CabDr3mAWw8_1i1Vt5_iOKTR4FNUBKhU4sd0mF-Xn_bHSh5RiPsldIB7qCeKL4qOnCmSmjmxOQCCU7anmrJ7X3U92IA&_hsmi=319729615&utm_content=319691242&utm_source=hs_email